Shared genetic architecture of cortical thickness alterations in major depressive disorder and schizophrenia

IF 5.3 2区 医学 Q1 CLINICAL NEUROLOGY
{"title":"Shared genetic architecture of cortical thickness alterations in major depressive disorder and schizophrenia","authors":"","doi":"10.1016/j.pnpbp.2024.111121","DOIUrl":null,"url":null,"abstract":"<div><h3>Background</h3><p>Major depressive disorder (MDD) and schizophrenia (SCZ) are heritable brain disorders characterized by alterations in cortical thickness. However, the shared genetic basis for cortical thickness changes in these disorders remains unclear.</p></div><div><h3>Methods</h3><p>We conducted a systematic literature search on cortical thickness in MDD and SCZ through PubMed and Web of Science. A coordinate-based meta-analysis was performed to identify cortical thickness changes. Additionally, utilizing summary statistics from the largest genome-wide association studies for depression (<em>N</em><sub>case</sub> = 268,615, <em>N</em><sub>control</sub> = 667,123) and SCZ (<em>N</em><sub>case</sub> = 53,386, <em>N</em><sub>control</sub> = 77,258), we explored shared genomic loci using conjunctional false discovery rate (conjFDR) analysis. Transcriptome-neuroimaging association analysis was then employed to identify shared genes associated with cortical thickness alterations, and enrichment analysis was finally carried out to elucidate the biological significance of these genes.</p></div><div><h3>Results</h3><p>Our search yielded 34 MDD (<em>N</em><sub>case</sub> = 1621, <em>N</em><sub>control</sub> = 1507) and 19 SCZ (<em>N</em><sub>case</sub> = 1170, <em>N</em><sub>control</sub> = 1043) neuroimaging studies for cortical thickness meta-analysis. Specific alterations in the left supplementary motor area were observed in MDD, while SCZ exhibited widespread reductions in various brain regions, particularly in the frontal and temporal areas. The conjFDR approach identified 357 genomic loci jointly associated with MDD and SCZ. Within these loci, 55 genes were found to be associated with cortical thickness alterations in both disorders. Enrichment analysis revealed their involvement in nervous system development, apoptosis, and cell communication.</p></div><div><h3>Conclusion</h3><p>This study revealed the shared genetic architecture underlying cortical thickness alterations in MDD and SCZ, providing insights into common neurobiological pathways. The identified genes and pathways may serve as potential transdiagnostic markers, informing precision medicine approaches in psychiatric care.</p></div>","PeriodicalId":54549,"journal":{"name":"Progress in Neuro-Psychopharmacology & Biological Psychiatry","volume":null,"pages":null},"PeriodicalIF":5.3000,"publicationDate":"2024-08-21","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Progress in Neuro-Psychopharmacology & Biological Psychiatry","FirstCategoryId":"3","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S0278584624001891","RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"CLINICAL NEUROLOGY","Score":null,"Total":0}
引用次数: 0

Abstract

Background

Major depressive disorder (MDD) and schizophrenia (SCZ) are heritable brain disorders characterized by alterations in cortical thickness. However, the shared genetic basis for cortical thickness changes in these disorders remains unclear.

Methods

We conducted a systematic literature search on cortical thickness in MDD and SCZ through PubMed and Web of Science. A coordinate-based meta-analysis was performed to identify cortical thickness changes. Additionally, utilizing summary statistics from the largest genome-wide association studies for depression (Ncase = 268,615, Ncontrol = 667,123) and SCZ (Ncase = 53,386, Ncontrol = 77,258), we explored shared genomic loci using conjunctional false discovery rate (conjFDR) analysis. Transcriptome-neuroimaging association analysis was then employed to identify shared genes associated with cortical thickness alterations, and enrichment analysis was finally carried out to elucidate the biological significance of these genes.

Results

Our search yielded 34 MDD (Ncase = 1621, Ncontrol = 1507) and 19 SCZ (Ncase = 1170, Ncontrol = 1043) neuroimaging studies for cortical thickness meta-analysis. Specific alterations in the left supplementary motor area were observed in MDD, while SCZ exhibited widespread reductions in various brain regions, particularly in the frontal and temporal areas. The conjFDR approach identified 357 genomic loci jointly associated with MDD and SCZ. Within these loci, 55 genes were found to be associated with cortical thickness alterations in both disorders. Enrichment analysis revealed their involvement in nervous system development, apoptosis, and cell communication.

Conclusion

This study revealed the shared genetic architecture underlying cortical thickness alterations in MDD and SCZ, providing insights into common neurobiological pathways. The identified genes and pathways may serve as potential transdiagnostic markers, informing precision medicine approaches in psychiatric care.

重度抑郁障碍和精神分裂症皮层厚度改变的共同遗传结构。
背景:重度抑郁障碍(MDD)和精神分裂症(SCZ)是以皮质厚度改变为特征的遗传性脑部疾病。然而,这些疾病皮质厚度变化的共同遗传基础仍不清楚:我们通过 PubMed 和 Web of Science 对 MDD 和 SCZ 的皮质厚度进行了系统的文献检索。我们进行了基于坐标的荟萃分析,以确定皮质厚度的变化。此外,我们还利用最大的抑郁症(Ncase = 268,615, Ncontrol = 667,123 )和SCZ(Ncase = 53,386, Ncontrol = 77,258 )全基因组关联研究的汇总统计数据,使用联合错误发现率(conjunctional false discovery rate,conjFDR)分析探索了共享基因组位点。然后采用转录组-神经影像关联分析来确定与皮质厚度改变相关的共有基因,最后进行富集分析以阐明这些基因的生物学意义:结果:我们通过检索获得了34项MDD(Ncase = 1621,Ncontrol = 1507)和19项SCZ(Ncase = 1170,Ncontrol = 1043)神经影像学研究的皮质厚度荟萃分析结果。在 MDD 中观察到了左侧辅助运动区的特殊改变,而 SCZ 则表现出大脑各区域的广泛减少,尤其是额叶和颞叶区域。conjFDR方法确定了357个与MDD和SCZ共同相关的基因组位点。在这些基因位点中,发现55个基因与这两种疾病的皮层厚度改变有关。富集分析显示,这些基因参与了神经系统发育、细胞凋亡和细胞通讯:这项研究揭示了MDD和SCZ皮层厚度改变的共同基因结构,为共同的神经生物学途径提供了见解。所发现的基因和通路可作为潜在的跨诊断标志物,为精神病治疗中的精准医学方法提供信息。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
CiteScore
12.00
自引率
1.80%
发文量
153
审稿时长
56 days
期刊介绍: Progress in Neuro-Psychopharmacology & Biological Psychiatry is an international and multidisciplinary journal which aims to ensure the rapid publication of authoritative reviews and research papers dealing with experimental and clinical aspects of neuro-psychopharmacology and biological psychiatry. Issues of the journal are regularly devoted wholly in or in part to a topical subject. Progress in Neuro-Psychopharmacology & Biological Psychiatry does not publish work on the actions of biological extracts unless the pharmacological active molecular substrate and/or specific receptor binding properties of the extract compounds are elucidated.
文献相关原料
公司名称 产品信息 采购帮参考价格
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信